| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Topper James N is a Director at NewAmsterdam Pharma Co N.V. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $121.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2024 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 8,429 | $21.50 | $181,223.50 | +0.3% | -13.6% | -0.7% | |
| Jan 31, 2017 | ANAB Anaptysbio, Inc | Director, 10% Owner | Buy | 400,000 | $15.00 | $6,000,000.00 | +42.4% | - | - |